Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Business Description
We are a leading provider of manufactured
vinyl coated fabrics. Our best-known brand, Naugahyde, is the product of many improvements on a rubber-coated fabric developed
a century ago in Naugatuck, Connecticut. We design, manufacture and market a wide selection of vinyl coated fabric products under
a portfolio of recognized brand names. We believe that our business has continued to be a leading supplier in its marketplace because
of our ability to provide specialized materials with performance characteristics customized to the end-user specifications, complemented
by technical and customer support for the use of our products in manufacturing.
Our vinyl coated fabric products have undergone
considerable evolution and today are distinguished by superior performance in a wide variety of applications as alternatives to
leather, cloth and other synthetic fabric coverings. Our standard product lines consist of more than 600 SKUs with combinations
of colors, textures, patterns and other properties. Our products are differentiated by unique protective top finishes and transfer
print capabilities. Additional process capabilities include embossing grains and patterns, and rotogravure printing, which imparts
five color character prints and non-registered prints, lamination and panel cutting.
Our vinyl coated fabric products have various
high-performance characteristics and capabilities. They are durable, stain resistant, easily processed, more cost-effective and
better performing than traditional leather or fabric coverings. Our products are frequently used in applications that require rigorous
performance characteristics such as automotive and non-automotive transportation, certain indoor/outdoor furniture, commercial
and hospitality seating, healthcare facilities and athletic equipment. We manufacture materials in a wide range of colors and textures.
They can be hand or machine sewn, laminated to an underlying structure, thermoformed to cover various substrates or made into a
variety of shapes for diverse end-uses. We are a long-established supplier to the global automotive industry and manufacture products
for interior soft trim components from floor to headliner, which are produced to meet specific component production requirements
such as cut and sew, vacuum forming/covering, compression molding, and high frequency welding. Some products are supplied with
micro perforations, which are necessary on most compression molding processes. Materials can also be combined with polyurethane
or polypropylene foam laminated by either flame or hot melt adhesive for seating, fascia and door applications.
Products are developed and marketed based
upon the performance characteristics required by end-users. For example, for recreational products used outdoors, such as boats,
personal watercraft, golf carts and snowmobiles, a product designed primarily for water-based durability and weatherability is
used. We also manufacture a line of products called BeautyGard
®
, with water-based topcoats that contain agents
to protect against bacterial and fungal micro-organisms and can withstand repeated cleaning, a necessity in the restaurant and
health care industries. These topcoats are environmentally friendlier than solvent-based topcoats. The line is widely used in
hospitals and other healthcare facilities. Flame and smoke retardant vinyl coated fabrics are used for a variety of commercial
and institutional furniture applications, including hospitals, restaurants and residential care centers and seats for school buses,
trains and aircraft.
We currently conduct our operations in
manufacturing facilities that are located in Stoughton, Wisconsin and Earby, England.
Critical Accounting Policies and Estimates
The preparation of our Consolidated Financial
Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires
management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and
related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based
upon historical experience and various other factors and circumstances. We believe that our estimates and assumptions are reasonable
under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances.
For further discussion of our significant accounting policies, refer to Note 1 – “Summary of Significant Accounting
Policies” to the Consolidated Financial Statements and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations – Critical Accounting Policies, Judgments and Estimates” in our Annual Report on Form 10-K
for the fiscal year ended December 30, 2018.
Recent Accounting Pronouncements
See Note 15 – “Recent Accounting
Standards” to the Consolidated Financial Statements for a discussion of recent accounting guidance.
Overview:
The Company and its subsidiaries use a
52/53-week fiscal year ending on the Sunday nearest to December 31. The current year ending December 29, 2019 and the prior year
ended December 30, 2018 are 52-week years.
Our Earby, England operation’s functional
currency is the British Pound Sterling and has sales and purchases transactions that are denominated in currencies other than the
Pound Sterling, principally the Euro. Approximately 29% of the Company’s global revenues and 32% of its global raw material
purchases are derived from these Euro transactions.
The average year-to-date exchange rate
for the Pound Sterling to the U.S. Dollar was approximately 6.0% lower and the average exchange rate for the Euro to the Pound
Sterling was approximately 0.7% lower in 2019 compared to 2018. These exchange rate changes had the effect of decreasing net sales
by approximately $1.7 million for the six months ended June 30, 2019. The overall currency effect on the Company’s net loss
was a negative amount of approximately $19,000 for the six months ended June 30, 2019.
Three Months Ended June 30, 2019 Compared
to the Three Months Ended July 1, 2018
The following table sets forth, for the
three months ended June 30, 2019 (“three months 2019”) and July 1, 2018 (“three months 2018”), certain
operations data including their respective percentage of net sales:
|
|
Three Months Ended
|
|
|
|
June 30, 2019
|
|
|
July 1, 2018
|
|
|
Change
|
|
|
%
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
24,095,783
|
|
|
|
100.0
|
%
|
|
$
|
26,023,233
|
|
|
|
100.0
|
%
|
|
$
|
(1,927,450
|
)
|
|
|
-7.4
|
%
|
Cost of Sales
|
|
|
19,883,392
|
|
|
|
82.5
|
%
|
|
|
21,259,055
|
|
|
|
81.7
|
%
|
|
|
(1,375,663
|
)
|
|
|
-6.5
|
%
|
Gross Profit
|
|
|
4,212,391
|
|
|
|
17.5
|
%
|
|
|
4,764,178
|
|
|
|
18.3
|
%
|
|
|
(551,787
|
)
|
|
|
-11.6
|
%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
1,183,803
|
|
|
|
4.9
|
%
|
|
|
1,200,051
|
|
|
|
4.6
|
%
|
|
|
(16,248
|
)
|
|
|
-1.4
|
%
|
General and administrative
|
|
|
1,449,060
|
|
|
|
6.0
|
%
|
|
|
1,658,665
|
|
|
|
6.4
|
%
|
|
|
(209,605
|
)
|
|
|
-12.6
|
%
|
Research and development
|
|
|
447,754
|
|
|
|
1.9
|
%
|
|
|
430,565
|
|
|
|
1.7
|
%
|
|
|
17,189
|
|
|
|
4.0
|
%
|
Total Operating Expenses
|
|
|
3,080,617
|
|
|
|
12.8
|
%
|
|
|
3,289,281
|
|
|
|
12.6
|
%
|
|
|
(208,664
|
)
|
|
|
-6.3
|
%
|
Operating Income
|
|
|
1,131,774
|
|
|
|
4.7
|
%
|
|
|
1,474,897
|
|
|
|
5.7
|
%
|
|
|
(343,123
|
)
|
|
|
-23.3
|
%
|
Interest expense
|
|
|
(523,218
|
)
|
|
|
-2.2
|
%
|
|
|
(473,663
|
)
|
|
|
-1.8
|
%
|
|
|
(49,555
|
)
|
|
|
10.5
|
%
|
Other expense
|
|
|
(224,950
|
)
|
|
|
-0.9
|
%
|
|
|
(19,220
|
)
|
|
|
-0.1
|
%
|
|
|
(205,730
|
)
|
|
|
>100%
|
|
Income before Taxes
|
|
|
383,606
|
|
|
|
1.6
|
%
|
|
|
982,014
|
|
|
|
3.8
|
%
|
|
|
(598,408
|
)
|
|
|
-60.9
|
%
|
Tax provision
|
|
|
20,559
|
|
|
|
0.1
|
%
|
|
|
57,521
|
|
|
|
0.2
|
%
|
|
|
(36,962
|
)
|
|
|
-64.3
|
%
|
Net Income
|
|
|
363,047
|
|
|
|
1.5
|
%
|
|
|
924,493
|
|
|
|
3.6
|
%
|
|
|
(561,446
|
)
|
|
|
-60.7
|
%
|
Preferred dividends
|
|
|
(779,946
|
)
|
|
|
-3.2
|
%
|
|
|
(776,104
|
)
|
|
|
-3.0
|
%
|
|
|
(3,842
|
)
|
|
|
0.5
|
%
|
Net Income (Loss) Allocable to
Common Shareholders
|
|
$
|
(416,899
|
)
|
|
|
-1.7
|
%
|
|
$
|
148,389
|
|
|
|
0.6
|
%
|
|
$
|
(565,288
|
)
|
|
|
<-100%
|
|
Revenue:
Total revenue for the three months 2019
decreased $1,927,450 or 7.4% to $24,095,783 from $26,023,233 for the three months 2018. Excluding the negative currency effect
of the exchange rates, total revenue would have only decreased by approximately $1.2 million or 4.6%. U.S. automotive sales for
the three months 2019 increased 3.6% compared to the three months 2018 resulting from new automotive programs in 2019. European
automotive sales decreased 11.9% compared to the prior year excluding the currency adjustment. Sales for the three months 2019
for the industrial sector increased 1.2% (2.3% before currency effect) compared to the three months 2018 as a decline in the U.S.
contract market was offset by an increase in sales from the non-automotive transportation market.
Gross Profit:
Total gross profit for the three months
2019 decreased $551,787 or 11.6% to $4,212,391 from $4,764,178 for the three months 2018. The gross profit percentage was 17.5%
of sales for the three months 2019 compared to 18.3% for the three months 2018. Gross profit amount and percentage was negatively
impacted in 2019 by higher raw material prices compared to 2018 and the effects of product mix. To offset raw material price increases,
the Company increased prices during the first three months of 2019 in several of its markets. The decrease in gross profit included
a negative net currency effect of $123,000. Excluding this effect, gross profit would have only declined by 9.0%
Operating Expenses:
Selling expenses for the three months 2019
decreased $16,248 or 1.4% to $1,183,803 from $1,200,051 for the three months 2018. The Company pays commissions only on certain
U.K. automotive programs. In conjunction with the decline in total automotive sales in the U.K. for the three months 2019, there
was a decrease in commissionable sales. The decrease in selling expense for the three months 2019 was attributable to the lower
commissions related to these sales. Also contributing to the decrease was the favorable currency effect of $35,000. This decrease
was partially offset by increases in employment related costs.
General and administrative expenses for
the three months 2019 decreased $209,605 or 12.6% to $1,449,060 from $1,658,665 for the three months 2018. This decrease was primarily
attributable to a decrease in employment costs for the three months 2019 compared to the three months 2018. Also contributing to
the decrease was the favorable currency effect of $49,000.
Research and development expenses for the
three months 2019 increased $17,189 or 4.0% to $447,754 from $430,565 for the three months 2018. The increase was principally attributable
to development costs for new trials which was partially offset by the favorable currency effect of $14,000.
Operating Income:
Operating income for the three months 2019
decreased $343,123 or 23.3% to $1,131,774 from $1,474,897 for the three months 2018. The operating income percentage was 4.7% of
sales for the three months 2019 compared to 5.7% for the three months 2018. Operating income decreased from the decrease in gross
profit which was partially offset by the decrease in operating expenses.
Interest Expense:
Interest expense for the three months 2019
increased $49,555 or 10.5% to $523,218 from $473,663 for the three months 2018. The increase was primarily due to new equipment
purchases and higher interest rates on LIBOR and prime during the three months 2019 partially offset by debt repayments compared
to the three months 2018.
Other Expense:
Other expense for the three months 2019
increased $205,730 to $224,950 from $19,220 for the three months 2018. Included in other expense are the currency gains and losses
recognized on foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated
in Euros as these currencies fluctuated during the quarter. Also included in other expense are gains and losses from the change
in fair values on the Company’s foreign currency exchange contracts.
Tax Provision:
The Company files income tax returns in
the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s U.S. operating
subsidiary, Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses,
and credits are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company,
which issued preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income
is allocated entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to
the sellers of Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred
ownership interests is reported to the sellers who report it on their respective individual tax returns.
For the three months 2019, the tax provision was $20,559 as
compared to $57,521 for the three months 2018. The lower provision is due to a decrease in taxable income in the U.K.
Preferred Stock Dividend:
The terms of the acquisitions in November
2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers.
These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to
7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary
of the issuance up to a maximum of 8.0%.
Six Months Ended June 30, 2019 Compared
to the Six Months Ended July 1, 2018
The following table sets forth, for the
six months ended June 30, 2019 (“six months 2019”) and July 1, 2018 (“six months 2018”), certain operations
data including their respective percentage of net sales:
|
|
Six Months Ended
|
|
|
|
June 30, 2019
|
|
|
July 1, 2018
|
|
|
Change
|
|
|
%
Change
|
|
Net Sales
|
|
$
|
49,489,643
|
|
|
|
100.0
|
%
|
|
$
|
52,452,920
|
|
|
|
100.0
|
%
|
|
$
|
(2,963,277
|
)
|
|
|
-5.6
|
%
|
Cost of Sales
|
|
|
40,963,050
|
|
|
|
82.8
|
%
|
|
|
43,071,248
|
|
|
|
82.1
|
%
|
|
|
(2,108,198
|
)
|
|
|
-4.9
|
%
|
Gross Profit
|
|
|
8,526,593
|
|
|
|
17.2
|
%
|
|
|
9,381,672
|
|
|
|
17.9
|
%
|
|
|
(855,079
|
)
|
|
|
-9.1
|
%
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
2,286,841
|
|
|
|
4.6
|
%
|
|
|
2,549,081
|
|
|
|
4.9
|
%
|
|
|
(262,240
|
)
|
|
|
-10.3
|
%
|
General and administrative
|
|
|
2,959,860
|
|
|
|
6.0
|
%
|
|
|
3,606,966
|
|
|
|
6.9
|
%
|
|
|
(647,106
|
)
|
|
|
-17.9
|
%
|
Research and development
|
|
|
924,718
|
|
|
|
1.9
|
%
|
|
|
852,528
|
|
|
|
1.6
|
%
|
|
|
72,190
|
|
|
|
8.5
|
%
|
Other operating expenses
|
|
|
343,003
|
|
|
|
0.7
|
%
|
|
|
-
|
|
|
|
0.0
|
%
|
|
|
343,003
|
|
|
|
-
|
|
Total Operating Expenses
|
|
|
6,514,422
|
|
|
|
13.2
|
%
|
|
|
7,008,575
|
|
|
|
13.4
|
%
|
|
|
(494,153
|
)
|
|
|
-7.1
|
%
|
Operating Income
|
|
|
2,012,171
|
|
|
|
4.1
|
%
|
|
|
2,373,097
|
|
|
|
4.5
|
%
|
|
|
(360,926
|
)
|
|
|
-15.2
|
%
|
Interest expense
|
|
|
(1,037,514
|
)
|
|
|
-2.1
|
%
|
|
|
(930,027
|
)
|
|
|
-1.8
|
%
|
|
|
(107,487
|
)
|
|
|
11.6
|
%
|
Other income
|
|
|
3,183
|
|
|
|
0.0
|
%
|
|
|
14,062
|
|
|
|
0.0
|
%
|
|
|
(10,879
|
)
|
|
|
-77.4
|
%
|
Income before Taxes
|
|
|
977,840
|
|
|
|
2.0
|
%
|
|
|
1,457,132
|
|
|
|
2.8
|
%
|
|
|
(479,292
|
)
|
|
|
-32.9
|
%
|
Tax provision (benefit)
|
|
|
(18,309
|
)
|
|
|
0.0
|
%
|
|
|
43,000
|
|
|
|
0.1
|
%
|
|
|
(61,309
|
)
|
|
|
<-100%
|
|
Net Income
|
|
|
996,149
|
|
|
|
2.0
|
%
|
|
|
1,414,132
|
|
|
|
2.7
|
%
|
|
|
(417,983
|
)
|
|
|
-29.6
|
%
|
Preferred dividends
|
|
|
(1,562,490
|
)
|
|
|
-3.2
|
%
|
|
|
(1,560,563
|
)
|
|
|
-3.0
|
%
|
|
|
(1,927
|
)
|
|
|
0.1
|
%
|
Net Loss Allocable to Common Shareholders
|
|
$
|
(566,341
|
)
|
|
|
-1.1
|
%
|
|
$
|
(146,431
|
)
|
|
|
-0.3
|
%
|
|
$
|
(419,910
|
)
|
|
|
>100%
|
|
Revenue:
Total revenue for the six months 2019 decreased
$2,963,277 or 5.6% to $49,489,643 from $52,452,920 for the six months 2018. Excluding the negative currency effect of the exchange
rates, total revenue would have only decreased by approximately $1.2 million or 2.3%. U.S. automotive sales for the six months
2019 increased 3.0% compared to the six months 2018 as a result of new automotive programs in 2019. European automotive sales decreased
6.4% compared to the prior year excluding the currency adjustment. Sales for the six months 2019 for the industrial sector decreased
1.1% (or a marginal increase of 0.1% before currency effect) compared to the six months 2018 as a decline in the U.S. contract
market was partially offset by an increase in sales from the non-automotive transportation market.
Gross Profit:
Total gross profit for the six months 2019
decreased $855,079 or 9.1% to $8,526,593 from $9,381,672 for the six months 2018. The gross profit percentage was 17.2% of sales
for the six months 2019 compared to 17.9% for the six months 2018. Gross profit amount and percentage was negatively impacted in
2019 by higher raw material prices compared to 2018 and the effects of product mix. To offset raw material price increases, the
Company increased prices during the first three months of 2019 in several of its markets. The decrease in gross profit included
a negative net currency effect of $275,000. Excluding this effect, gross profit would have only declined by 6.2%
Operating Expenses:
Selling expenses for the six months 2019
decreased $262,240 or 10.3% to $2,286,841 from $2,549,081 for the six months 2018. The Company pays commissions only on certain
U.K. automotive programs. In conjunction with the decline in total automotive sales in the U.K. for the six months 2019, there
was a decrease in commissionable sales. The decrease in selling expense for the six months 2019 was principally attributable to
the lower commissions related to these sales. Also contributing to the decrease was the favorable currency effect of $80,000. This
decrease was partially offset by increases in employment related costs.
General and administrative expenses for
the six months 2019 decreased $647,106 or 17.9% to $2,959,860 from $3,606,966 for the six months 2018. This decrease was primarily
attributable to a decrease in employment costs for the six months 2019 compared to the six months 2018. Also contributing to the
decrease was the favorable currency effect of $109,000.
Research and development expenses for the
six months 2019 increased $72,190 or 8.5% to $924,718 from $852,528 for the six months 2018. The increase was principally attributable
to development costs for new trials which was partially offset by the favorable currency effect of $32,000.
Other operating expenses for the six months
2019 was $343,003. There was not a corresponding amount for the six months 2018. This amount is cost incurred by the Company as
part of a restructuring plan to reduce inefficiencies at its U.K. facility.
Operating Income:
Operating income for the six months 2019
decreased $360,926 or 15.2% to $2,012,171 from $2,373,097 for the six months 2018. The operating income percentage was 4.1% of
sales for the six months 2019 compared to 4.5% for the six months 2018. Operating income decreased from the decrease in gross profit
which was partially offset by the decrease in operating expenses.
Interest Expense:
Interest expense for the six months 2019
increased $107,487 or 11.6% to $1,037,514 from $930,027 for the six months 2018. The increase was primarily due to new equipment
purchases and higher interest rates on LIBOR and prime during the six months 2019 partially offset by debt repayments compared
to the six months 2018.
Other Income:
Other income for the six months 2019 decreased
$10,879 to $3,183 from $14,062 for the six months 2018. Included in other income are the currency gains and losses recognized on
foreign currency transactions and the change in the fair value of financial assets and liabilities that are denominated in Euros
as these currencies fluctuated during the year. Also included in other income are gains and losses from the change in fair values
on the Company’s foreign currency exchange contracts.
Tax Provision (Benefit):
The Company files income tax returns in
the United States as a C-Corporation, and in several state jurisdictions and in the United Kingdom. The Company’s subsidiary,
Uniroyal, is a limited liability company (LLC) for federal and state income tax purposes and as such, its income, losses, and credits
are allocated to its members. The Company made the acquisition of Uniroyal through UEPH, a limited liability company, which issued
preferred ownership interests to the sellers that provide for quarterly dividends. Uniroyal’s taxable income is allocated
entirely to UEPH as its sole member and since it is a pass-through entity, this income less the dividends paid to the sellers of
Uniroyal is reported on the Company’s tax return. The taxable income applicable to the dividends for the preferred ownership
interests is reported to the sellers who report it on their respective individual tax returns.
For the six months 2019, the tax benefit
was $18,309 as compared to a tax provision of $43,000 for the six months 2018. The tax benefit for 2019 and the tax provision for
2018 were principally attributable to the results of the U.K. operations.
Preferred Stock Dividend:
The terms of the acquisitions in November
2014 resulted in the issuance of preferred ownership units/stock of UEP Holdings, LLC and UGEL (formerly EPAL) to the sellers.
These preferred units have carried quarterly dividend requirements on a total value of $55,000,000 at rates ranging from 5.0% to
7.5%. The dividend rate on the Series B UEP Holdings preferred units which started at 5.5% increases by 0.5% on the anniversary
of the issuance up to a maximum of 8.0%.
Liquidity and Sources of Capital
Cash, as it is needed, is provided by using
the Company’s lines of credit. These lines provide for a total borrowing commitment in excess of $42,000,000 subject to the
underlying borrowing base specified in the agreements. Of the total outstanding borrowings of $21,196,050 at June 30, 2019, $15.2
million of the lines bears interest at LIBOR or the Eurodollar rate plus a range of 1.95% to 2.45%, depending on the underlying
borrowing base and $6 million bears interest at the bank’s prime or base lending rate which was 5.5% at June 30, 2019. At
June 30, 2019, the lines provided an additional availability of approximately $2.1 million. We plan to use this availability and
cash provided by operating activities to finance our cash needs for the remaining months of fiscal 2019 and future periods. The
balances due under the lines of credit are recorded as current liabilities on the Consolidated Balance Sheets.
Given our capital resources in the U.S.
and the potential for increased investment and acquisitions in foreign jurisdictions, we did not have a history of repatriating
a significant portion of our foreign cash. Accordingly, we had not recognized a deferred tax liability for these unremitted earnings.
However, the Tax Cuts and Jobs Act of 2017 imposed a one-time transition tax on deemed repatriation of deferred foreign income,
which the Company recorded in tax expense in 2017. In the event that we decide to repatriate these foreign amounts to fund U.S.
operations, the Company will not be required to pay any additional U.S. tax related to these amounts.
The ratio of current assets to current
liabilities, including the amount due under our lines of credit, was 0.94 at June 30, 2019 and 0.97 at December 30, 2018.
Cash balances decreased $309,344 before
the effects of currency translation of $4,701, to $724,198 at June 30, 2019 from $1,028,841 at December 30, 2018. Of the above
noted amounts, $694,432 and $923,071 were held outside the U.S. by our foreign subsidiaries as of June 30, 2019 and December 30,
2018, respectively.
Cash provided by operations was $805,473
for the six months 2019 compared to $2,067,906 provided by operations for the six months 2018. For the six months 2019, cash provided
by operations was primarily due to adjustments for non-cash items of $1,109,420, net income of $996,149 and changes in other assets
and liabilities of $41,131 offset by changes in working capital of $(1,341,227). For the six months 2018, cash provided by operations
was primarily due to net income of $1,414,132 and adjustments for non-cash items of $1,214,211 offset by cash flows related to
changes in working capital of $(478,858) and changes in other assets and liabilities of $(81,579).
Cash used in investing activities was $826,643
for the six months 2019 compared to $1,383,284 for the six months 2018. During 2019 and 2018, cash used in investing activities
was principally for purchases of machinery and equipment at our manufacturing locations and payments made for company-owned key
man life insurance premiums.
For the six months 2019, cash used in financing
activities was $288,174 as compared to $1,041,081 used in financing activities for the six months 2018. Impacting cash flows from
financing activities for the six months 2019 and 2018 were net advances on lines of credit of $1,707,469 and $389,712, respectively.
The increases in advances on the lines of credit were used to fund working capital. Also included in cash flows from financing
activities were preferred dividend payments of $1,560,822 and $1,553,806 during the six months 2019 and 2018, respectively. During
the six months 2019 and 2018, our majority shareholder provided $200,000 and $272,000, respectively, in financing in the form of
subordinated secured promissory notes. During the six months 2018, we drew $486,067 on an equipment financing commitment from our
bank to finance asset purchases.
Our credit agreements contain customary
affirmative and negative covenants. We were in compliance with our debt covenants as of June 30, 2019 and through the date of filing
of this report.
We currently have several on-going capital
projects that are important to our long-term strategic goals. Machinery and equipment will also be added as needed to increase
capacity or enhance operating efficiencies in our manufacturing plants. We will use a combination of financing arrangements to
provide the necessary capital. We believe that our existing resources, including cash on hand and our credit facilities, together
with cash generated from operations and additional bank borrowings, will be sufficient to fund our cash flow requirements through
at least the next twelve months. However, there can be no assurance that additional financing will be available on favorable terms,
if at all.
We have no material off balance sheet arrangements.